The trading of Leadman shares has been suspended since 6 th August 2014, Leadman is scheduled to buy 45% shares of DiaSys Diagnostic Systems Greater China and 39% shares of DiaSys Diagnostic Products Greater China from the investment partne...
The financial report contains the balance sheet of 31 st August 2014, 31 st December 2013 and 31 st December 2012 of DiaSys Diagnostic Systems Greater China, and the profit statement, statement of change in equity, cash flow statement, and...
The fourth extraordinary general meeting of Leadman will be on 24 th November 2014. Location: Meeting-2 2 nd Floor, Beijing Leadman Biochemistry Co. Ltd., No.5 Xinghai Road BDA Beijing. For more information, please find on http://www.cninfo...
The independent directors of Leadman Mr. Ruiqi Wang, Zhongyi Su, Mingzhi Ma published their own opinion about the assets reorganization program of joint venture between Leadman and DiaSys China. They agreed that the assets reorganization pr...
October 31th,2014,PM 02:30,Leadman held Investor Meeting to communicate with investors their concerning issues about company management,developing strategies,current assets, fund-raising plans,equity motivation,sustainable development. Lead...
